In 2022, there were, on average, 2.35 hospital beds per 1,000 population in the United States. Hospital bed density varied widely between the states, with South Dakota having 4.61 beds per thousand population, while there were just 1.6 hospital beds per thousand population available in Washington.

The countries with the highest density of hospital beds worldwide include Korea, Japan, Russia, and Germany. Japan has around 12.6 hospital beds per 1,000 population. On the other hand, the United States reported just 2.8 hospital beds per 1,000 population.

Hospital beds in the U.S.

Both the number of hospitals and the number of hospital beds in the U.S. have decreased in recent years. In 2022, there were an estimated 917 thousand hospital beds in the U.S. The largest proportion of hospitals in the U.S. have 500 or more beds, while the second largest proportion of hospitals had between 100 and 199 beds.

Hospital stays in the U.S.

Despite decreasing hospital bed density since 1975, the number of hospital admissions in the U.S. has increased since then, but has dropped since the COVID pandemic. The number of hospital admission per capita differed from state to state with rates highest in the District of Columbia.

In 2022, community hospitals in the United States had an average of 2.4 beds per 1,000 persons. The share of community hospital beds ranged from 1.6 to five beds per 1,000 persons across the country. The number of community hospital beds per 1,000 population in the United States decreased slightly from 2000 to 2022.

The average for 2020 based on 36 countries was 4.44 hospital beds. The highest value was in South Korea: 12.65 hospital beds and the lowest value was in Mexico: 0.99 hospital beds. The indicator is available from 1960 to 2021. Below is a chart for all countries where data are available.

Forecast: Density of Physicians Employed in Hospitals in the US 2022 - 2026 Discover more data with ReportLinker!

Context

Dataset aims to facilitate a state by state comparison of potential risk factors that may heighten Covid 19 transmission rates or deaths. It includes state by state estimates of: covid 19 positives/deaths, flu/pneumonia deaths, major city population densities, available hospital resources, high risk health condition prevalance, population over 60, and means of work transportation rates.

Content

The Data Includes:

1) Covid 19 Outcome Stats:

Covid_Death : Covid Deaths by State

Covid_Positive : Covid Positive Tests by State

2) US Major City Population Density by State: CBSA_Major_City_max_weighted_density

3) KFF Estimates of Total Hospital Beds by State:

Kaiser_Total_Hospital_Beds

4) 2018 Season Flu and Pneumonia Death Stats:

FLUVIEW_TOTAL_PNEUMONIA_DEATHS_Season_2018

FLUVIEW_TOTAL_INFLUENZA_DEATHS_Season_2018

5)US Total Rates of Flu Hospitalization by Underlying Condition:

Fluview_US_FLU_Hospitalization_Rate_....

6) State by State BRFSS Prevalance Rates of Conditions Associated with Higher Flu Hospitalization Rates

BRFSS_Diabetes_Prevalance BRFSS_Asthma_Prevalance BRFSS_COPD_Prevalance
BRFSS_Obesity BMI Prevalance BRFSS_Other_Cancer_Prevalance BRFSS_Kidney_Disease_Prevalance BRFSS_Obesity BMI Prevalance BRFSS_2017_High_Cholestoral_Prevalance BRFSS_2017_High_Blood_Pressure_Prevalance Census_Population_Over_60

7)State by state breakdown of Means of Work Transpotation:

COMMUTE_Census_Worker_Public_Transportation_Rate

Acknowledgements

Links to data sources:

https://worldpopulationreview.com/states/

https://covidtracking.com/data/

https://gis.cdc.gov/GRASP/Fluview/FluHospRates.html https://www.kff.org/health-costs/issue-brief/state-data-and-policy-actions-to-address-coronavirus/#stateleveldata

https://data.census.gov/cedsci/table?q=United%20States&tid=ACSDP1Y2018.DP05&hidePreview=true&vintage=2018&layer=VT_2018_040_00_PY_D1&cid=S0103_C01_001E

Tables: ACSST1Y2018.S1811 ACSST1Y2018.S0102

https://www.census.gov/library/visualizations/2012/dec/c2010sr-01-density.html

https://gis.cdc.gov/grasp/fluview/mortality.html

Inspiration

I hope to show the existence of correlations that warrant a deeper county by county analysis to identify areas of increased risk requiring increased resource allocation or increased attention to preventative measures.

Forecast: Density of Physicians Employed in Hospitals in the US 2024 - 2028 Discover more data with ReportLinker!

This dataset contains measures of the number and density of hospitals per United States Census Tract or ZIP Code Tabulation Area (ZCTA) in 2023. The dataset includes four separate files for four different geographic areas (GIS shapefiles from the United States Census Bureau). The four geographies include:Census Tract 2010Census Tract 2020ZIP Code Tabulation Area (ZCTA) 2010ZIP Code Tabulation Area (ZCTA) 2020Information about which dataset to use can be found in the Usage Notes section of the user guide.

Forecast: In Hospitals Magnetic Resonance Imaging Exams Density in the US 2022 - 2026 Discover more data with ReportLinker!

Forecast: Density of Professional Nurses and Midwives Employed in Hospitals in the US 2024 - 2028 Discover more data with ReportLinker!

Forecast: Density of Professional Nurses and Midwives Employed in Hospitals in the US 2022 - 2026 Discover more data with ReportLinker!

Forecast: Density of Associate Nurses Employed in Hospitals in the US 2023 - 2027 Discover more data with ReportLinker!

Forecast: Density of Associate Nurses Employed in Hospitals in the US 2024 - 2028 Discover more data with ReportLinker!

Forecast: Density of Generalist Medical Practitioners in the US 2024 - 2028 Discover more data with ReportLinker!

Medical Service Study Areas - Census Detail, 2010California Health & Human Services Agency Open Data Portal DescriptionMedical Service Study Areas (MSSAs) are sub-city and sub-county geographical units used to organize and display population, demographic and physician data. MSSAs were developed in 1976 by the California Healthcare Workforce Policy Commission (formerly California Health Manpower Policy Commission) to respond to legislative mandates requiring it to determine "areas of unmet priority need for primary care family physicians" (Song-Brown Act of 1973) and "geographical rural areas where unmet priority need for medical services exist" (Garamendi Rural Health Services Act of 1976).MSSAs are recognized by the U.S. Health Resources and Services Administration, Bureau of Health Professions' Office of Shortage Designation as rational service areas for purposes of designating Health Professional Shortage Areas (HPSAs), and Medically Underserved Areas and Medically Underserved Populations (MUAs/MUPs).The MSSAs incorporate the U.S. Census total population, socioeconomic and demographic data and are updated with each decadal census. Office of Statewide Health Planning and Development provides updated data for each County's MSSAs to the County and Communities, and will schedule meetings for areas of significant population change. Community meetings will be scheduled throughout the State as needed.Adopted by the California Healthcare Workforce Policy Commission on May 15, 2002.Each MSSA is composed of one or more complete census tracts. MSSAs will not cross county lines. All population centers within the MSSA are within 30 minutes travel time to the largest population center.Urban MSSA - Population range 75,000 to 125,000. Reflect recognized community and neighborhood boundaries. Similar demographic and socio-economic characteristics.Rural MSSA - Population density of less than 250 persons per square mile. No population center exceeds 50,000.Frontier MSSA - Population density of less than 11 persons per square mile.

Forecast: Density of Specialist Medical Practitioners in the US 2022 - 2026 Discover more data with ReportLinker!

Snapshot img

Womens Health Diagnostics Market Size 2024-2028

The womens health diagnostics market size is forecast to increase by USD 14.61 billion at a CAGR of 8.09% between 2023 and 2028.

The women's health diagnostics market is experiencing significant growth due to several key factors. The increasing prevalence of breast cancer worldwide is driving market demand, as early and accurate medical diagnostics is crucial for effective treatment. 
Another trend is the global adoption of advanced diagnostic solutions, which offer improved accuracy and efficiency compared to traditional methods. Stringent regulatory bodies are also guiding manufacturers of in-vitro diagnostics to ensure product safety and quality, further boosting market growth. These factors are expected to continue shaping the women's health diagnostics market In the coming years.

What will be the Size of the Womens Health Diagnostics Market During the Forecast Period?

Request Free Sample

The Women's Health Diagnostics Market encompasses a range of medical diagnostic devices and techniques aimed at detecting various conditions unique to women. Key diseases include breast, ovarian, and cervical cancers, as well as infectious diseases such as hepatitis and urinary tract infections. Diagnostic methods span imaging techniques like Breast MRI and ultrasound, bone density testing for osteoporosis, and breast cancer biopsy devices for cancer diagnosis. 
The geriatric female population is a significant market driver, given the increased prevalence of chronic conditions like cancer and osteoporosis. Medical science continues to advance, leading to the development of more sophisticated diagnostic tools and tests for pregnancy and menopause.
The market also caters to infectious diseases, with a growing focus on HIV/AIDS and other sexually transmitted infections. Overall, the Women's Health Diagnostics market is a vital sector in healthcare, providing essential tools for early detection and effective treatment of various conditions.

How is this Womens Health Diagnostics Industry segmented and which is the largest segment?

The womens health diagnostics industry research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in 'USD billion' for the period 2024-2028, as well as historical data from 2018-2022 for the following segments.

Application

  Breast cancer testing
  Infectious disease testing
  STD testing
  Cervical cancer testing
  Others


End-user

  Hospitals and clinics
  Diagnostic and imaging centers
  Home care settings


Geography

  North America

    Canada
    US


  Europe

    UK
    France


  Asia

    China


  Rest of World (ROW)

By Application Insights

The breast cancer testing segment is estimated to witness significant growth during the forecast period.

Women's health diagnostics encompass various medical tests and devices used to identify and manage conditions such as breast cancer, ovarian cancer, cervical cancer, menopause, pregnancy, and chronic conditions like osteoporosis and infectious diseases. Breast cancer diagnosis primarily relies on biopsy procedures, where a specialized needle and imaging techniques, such as mammography or ultrasound, guide the doctor to extract tissue samples for laboratory analysis. Biopsy devices, ultrasound devices, mammography systems, and diagnostic tests are essential medical diagnostics tools. The geriatric female population, hospitals and clinics, diagnostic centers, and home care settings utilize these devices. Diagnostic tests for breast cancer, cervical cancer, ovarian cancer, prenatal genetic screening, and infectious diseases like hepatitis, urinary tract infection, and HIV/AIDS are crucial.

Medical science advances continue to introduce new technologies, such as bone density testing, MRI, and genomic testing, to enhance diagnostic accuracy and patient care. Healthcare expenditure on diagnostic devices, accessories, and consumables is significant, with emerging countries increasingly investing in these technologies.

Get a glance at the Womens Health Diagnostics Industry report of share of various segments Request Free Sample

The Breast cancer testing segment was valued at USD 6.56 billion in 2018 and showed a gradual increase during the forecast period.

Regional Analysis

North America is estimated to contribute 43% to the growth of the global market during the forecast period.

Technavio's analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period.

For more insights on the market share of various regions, Request Free Sample

In North America, the adoption of advanced diagnostic technologies for women's health has been on the rise due to increasing healthcare expenditure, growing awareness about chronic diseases such as breast, ovarian, and cervical cancer, and the

Forecast: Density of Computed Tomography Scanners in Hospitals in the US 2022 - 2026 Discover more data with ReportLinker!

Forecast: In Hospitals Magnetic Resonance Imaging Units Density in the US 2023 - 2027 Discover more data with ReportLinker!